Granahan Investment Management - FATE THERAPEUTICS INC ownership

FATE THERAPEUTICS INC's ticker is FATE and the CUSIP is 31189P102. A total of 268 filers reported holding FATE THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 1.51 and the average weighting 0.3%.

Quarter-by-quarter ownership
Granahan Investment Management ownership history of FATE THERAPEUTICS INC
ValueSharesWeighting
Q4 2022$6,075,724
-16.9%
602,153
+84.5%
0.19%
-22.2%
Q3 2022$7,315,000
+12.2%
326,419
+24.0%
0.24%
+7.2%
Q2 2022$6,521,000
-17.9%
263,156
+28.4%
0.22%
+13.2%
Q1 2022$7,946,000
+1.8%
204,945
+53.6%
0.20%
+22.4%
Q4 2021$7,805,000
+76.8%
133,401
+79.1%
0.16%
+91.7%
Q3 2021$4,415,00074,4920.08%
Other shareholders
FATE THERAPEUTICS INC shareholders Q3 2021
NameSharesValueWeighting ↓
JOHNSON & JOHNSON 3,379,064$197,709,00022.51%
Redmile Group, LLC 12,957,222$758,127,00017.24%
Grosvenor Holdings, L.L.C. 1,037,256$60,690,0006.28%
Casdin Capital, LLC 3,400,000$198,934,0005.61%
Ally Bridge Group (NY) LLC 270,000$15,798,0005.52%
DAFNA Capital Management LLC 372,160$21,775,0005.48%
Tri Locum Partners LP 142,032$8,310,0003.27%
Kynam Capital Management, LP 95,561$5,591,0002.99%
Artal Group S.A. 1,800,000$105,318,0002.86%
Bellevue Group AG 3,775,736$220,918,0002.28%
View complete list of FATE THERAPEUTICS INC shareholders